Last Price$1.89Cboe Previous Close - Real-Time Last Sale as of 4:01PM ET 6/24/22
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$1.89 (100)
Ask (Size)$1.90 (38)
Day Low / HighN/A - N/A
Volume8.5 M

Agenus to Supply Adjuvant Under Cancer Vaccine Clinical Collaboration With Targovax ASA

8:16AM ET 3/07/2022 MT Newswires
Agenus (AGEN) has entered a clinical collaboration and supply agreement to combine its QS-21 Stimulon adjuvant with clinical stage biotechnology company Targovax ASA's TG vaccines for KRAS-mutated cancers, the companies said Monday.

Under the collaboration, Agenus will supply the adjuvant and scientific support for up to three initial TG01 clinical trials in different cancer indications.

If the clinical results meet certain performance targets, the collaboration will expand into an exclusive development and commercialization agreement where Agenus will be entitled to tiered double-digit royalties on future TG vaccine sales, the companies said.

Agenus shares gained about 1.4% in recent premarket activity Monday.

Price: 2.95, Change: +0.04, Percent Change: +1.37